This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maher, C. O. Articles by Pollock, B. E. Search for Related Content PubMed PubMed Citation Articles by Maher, C. O. Articles by Pollock, B. E. Related Collections Acute Cerebral Hemorrhage Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Genetics of Stroke Angiography Intracerebral Hemorrhage Risk Factors for Stroke Aneurysm, AVM, hematoma

(Stroke. 2001;32:877.)
© 2001 American Heart Association, Inc.

Original Contributions

Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia

Cormac O. Maher, MD; David G. Piepgras, MD; Robert D. Brown, Jr, MD; Jonathan A. Friedman, MD Bruce E. Pollock, MD

From the Departments of Neurosurgery (C.O.M., D.G.P., J.A.F., B.E.P.) and Neurology (R.D.B.), Mayo Clinic, Rochester, Minn.

Correspondence to Cormac O. Maher, MD, Mayo Clinic, 200 First St, SW, Rochester, MN 55905. E-mail maher.cormac{at}mayo.edu

	Abstract

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Background and Purpose—Patients with hereditary hemorrhagic telangiectasia (HHT) are at risk for developing cerebral vascular malformations and pulmonary arteriovenous fistulae. We assessed the risk of neurological dysfunction from these malformations and fistulae.

Methods—Three hundred twenty-one consecutive patients with HHT seen at a single institution over a 20-year period were studied. Any evidence of prior neurological symptoms or presence of an intracranial vascular malformation was recorded. All cases of possible cerebral arteriovenous malformation were confirmed by conventional arteriography.

Results—Twelve patients (3.7%) had a history of cerebral vascular malformations. Ten patients had arteriovenous malformations, 1 had a dural arteriovenous fistula, and 1 had a cavernous malformation. Seven patients (2.1%) presented with intracranial hemorrhage, 2 presented with seizures alone, and 3 were discovered incidentally. The average age at the time of symptomatic intracranial hemorrhage was 25.4 years. All patients with a history of intracranial hemorrhage were classified as Rankin grade I or II at a mean follow-up interval of 6.0 years. A history of cerebral infarction or transient ischemic attack was found in 29.6% of patients with HHT and a pulmonary arteriovenous fistula.

Conclusions—The risk of intracranial hemorrhage is low among people with HHT. Furthermore, a majority of these patients have a good functional outcome after hemorrhage. The data do not suggest a compelling indication for routine screening of patients with HHT for asymptomatic cerebral vascular malformations. By comparison, pulmonary arteriovenous fistulae are a much more frequent cause of neurological symptoms in this population.

Key Words: cerebral arteriovenous malformations • hereditary disease • intracerebral hemorrhage • stroke

	Introduction

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Hereditary hemorrhagic telangiectasia (HHT), or Rendu-Osler-Weber disease, is an inherited vascular dysplasia that is transmitted as an autosomal dominant trait with high penetrance and variable expressivity.¹ The estimated prevalence is 1 or 2 cases per 100 000.^{1 2} Chromosomes 9q and 12q have been implicated in the inheritance of this disease.^{3 4 5 6 7} A family history of HHT, although not required to make the diagnosis, is almost universally present. The vascular malformations of HHT may occur in multiple organs, including the lung, liver, kidney, and brain.^{8 9} Epistaxis is the most common presentation, followed by gastrointestinal bleeding.^{10 11} Pulmonary arteriovenous fistulae (AVFs) are often accompanied by dyspnea or hemoptysis and, less frequently, ischemic neurological symptoms.^{12 13 14} Telangiectasias are frequently noted on the skin and mucous membranes, often not appearing until the second or third decade.^{8 9}

Brown et al^{15 16} have reported that the detection rate of intracranial vascular malformations in a population-based study in the most recent time period was 2.75 per 100 000 person-years. The prevalence of intracranial hemorrhage from a vascular malformation was 7.50 per 100 000 people in the population at large.^{15 16} Patients with HHT are thought to be at increased risk for harboring cerebral vascular malformations compared with the entire population. Arteriovenous malformations (AVMs), cavernous malformations, dural arteriovenous fistulae, and aneurysms have all been reported in these patients (Figure 1).^{14 17 18 19 20 21 22 23 24} Vascular malformations are found throughout the central nervous system, including the spinal cord.²⁵ Several reports have analyzed the frequency of radiological detection of cerebral AVMs in this population.^{26 27 28} The risk of hemorrhage from these lesions, however, is an ongoing subject of debate. Because the risk of intracranial hemorrhage is low, it is necessary to evaluate a large number of patients to determine the clinical significance of cerebral AVMs. Furthermore, analysis of a consecutive series of patients from a single institution will minimize the reporting bias. We report our experience with a large consecutive series of HHT patients evaluated at a single institution between 1980 and 1999 to determine the occurrence of cerebral vascular malformations, associated neurological symptoms, and intracranial hemorrhage.

View larger version (90K): [in this window] [in a new window]   Figure 1. Case 2. Lateral (A) and anteroposterior (B) views of a left internal carotid injection angiogram demonstrating a single AVM with a compact nidus in a patient with HHT.

	Subjects and Methods

Top Abstract Introduction Subjects and Methods Results Discussion References

 
The medical records of 321 consecutive patients with HHT seen at the Mayo Clinic over a 20-year period were reviewed. There were 132 men and 189 women. The mean age at the time of the most recent evaluation was 50.3 years (range 6 to 85). In every case, the diagnosis of HHT was made or confirmed by a primary care physician at our institution. All patients underwent a complete general medical evaluation. All patients were asked to complete an inventory of current symptoms, past medical history, and family medical history at the time of their evaluation. The inventory of current symptoms included visual symptoms, hearing loss, slurred speech, seizures, or focal weakness. The inventory of past medical history included stroke or transient ischemic attack (TIA), as well as any intracranial procedures.

Although patients were not routinely radiologically screened for the presence of a cerebral vascular malformation, 70 patients underwent at least 1 head CT. Forty-six patients underwent a head MRI and 24 underwent a 4-vessel cerebral angiogram. CT or MRI confirmation was obtained for all cases of intracranial hemorrhage that were evaluated at our institution. All cases of cerebral AVM discovered on MRI or CT underwent catheter angiography. Patients were considered to have a cerebral AVM if the angiographic appearance was consistent with this diagnosis or, in operated cases, if pathological investigation confirmed the diagnosis. Angiographic criteria for AVM were the presence of a pial feeding vessel, a draining vein, and a nidus.

Patients were included without regard to the treatment for the malformations. Data collected included age at initial hemorrhage or ischemic event, presence of a family history of cerebral hemorrhage, location and number of malformations, type of intervention(s), and patient’s neurological condition at the time of the most recent evaluation. Functional status was assessed with the Rankin scale.²⁹ Those patients with a known pulmonary AVF were screened for a history of cerebral abscess, infarction, TIAs, and migraine headache. Age at the time of initial neurological symptoms, family history information, and therapeutic interventions were recorded.

	Results

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Twelve (3.7%) of 321 patients were found to have cerebral vascular malformations. There were 10 AVMs, 1 dural AVF, and 1 cavernous malformation (Table). Multiple vascular malformations were seen in 3 cases. The malformations were located supratentorially in 7 cases, infratentorially in 2 cases, and both supratentorially and infratentorially in 3 cases. Seven patients (2.1%) presented with symptoms of intracranial hemorrhage, 2 (0.6%) presented with seizures alone, and 3 cerebrovascular malformations (0.9%) were discovered incidentally. Neither of the 2 patients who presented with seizures had evidence of prior hemorrhage on MRI. Mean age at the time of hemorrhage was 25.4 years (range 8 to 50, SD 16.8). Three patients were sibling members of a single family.

View this table: [in this window] [in a new window]   Table 1. Summary of Patients With Cerebral Vascular Malformations

Cerebral vascular malformations were treated by excision in 8 patients and by radiosurgery in 2. In 2 cases, the vascular malformations were managed conservatively. After a mean follow-up interval of 6.0 years (SD 10.7), 10 patients were classified as a grade I on the Rankin disability scale, and 2 were grade II.²⁷ Six patients were neurologically intact, and 6 had a mild focal deficit, including hemiparesis in 5 patients and homonymous hemianopsia in 1. Two patients were unable to return to their prior level of functioning but were independent in all activities of daily living. Although both of these patients had undergone craniotomy for excision of their AVMs, the persistent hemiparesis was thought to be a result of the hemorrhage and not the surgical treatment.

Three patients were found to have multiple low-flow cerebral telangiectasias. None of the telangiectasias were known to have hemorrhaged, and none of the cerebral hemorrhages in this series were thought to be related to these lesions. In a single patient, cerebral telangiectasias were noted to develop over serial imaging.

Neurological symptoms were more likely to be secondary to pulmonary AVF than to cerebral vascular malformations. Seventy-one patients (22.1%) had a known pulmonary AVF. Of these, 21 (29.6%) had a history of cerebral infarction or TIA, and 5 (7.0%) had a history of 1 or more cerebral abscesses. Four of the 5 cases of cerebral abscesses were multiple or recurrent. A history of cerebrovascular embolic complications (TIA, cerebral infarction, or intracranial abscess) in patients with known pulmonary AVFs was present in 1 (10%) of 10 patients younger than 30 years, 11 (44%) of 25 patients between 31 and 50 years of age, and 14 (47%) of 30 patients older than 50 years. A history of migraine headaches was found in 18 (25.4%) of those with pulmonary AVF.

	Discussion

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Patients with HHT are at increased risk for developing cerebral AVMs. Roman et al,¹⁴ in reviewing collected cases in the literature, reported that cerebral vascular malformations were found in 36% of 215 cases of HHT with neurological manifestations. The majority of these were cavernous malformations and venous angiomas; AVMs were noted in only 7.9% of reported cases. It is difficult to derive AVM occurrence data, however, from a synthesis of case reports as a result of reporting bias. Fulbright et al²⁶ reported on MRI findings in a series of 184 patients with HHT. They found cerebral vascular malformations in 22.8% and true AVMs in 4.9% of these patients. Willemse et al²⁷ screened 196 patients with HHT for the presence of cerebral AVMs using digital subtraction angiography. Using this technique, they found cerebral AVMs in 11%. In the present series, the occurrence of cerebral AVM was lower (3.7%), most likely because of the absence of radiological screening in asymptomatic patients.

The risk of hemorrhage for unruptured nonsyndromic intracranial AVMs is 2% to 4% per year.^{30 31 32 33} For several reasons, it has been suggested that this rate may not be applicable to AVMs in the HHT population.²⁶ First, cerebral vascular malformations may be dynamic in HHT, like the pulmonary and gastrointestinal malformations that are known to enlarge over time.^{34 35 36 37} This dynamic tendency may not be relevant, however, to cerebral AVMs that are congenital in origin. Second, the majority of AVMs in HHT that have been described in the literature are smaller than 25 mm in maximum diameter.^{22 23 26} Some studies have suggested a correlation between small AVM size and an increased risk of hemorrhage,^{32 38 39} although this has not been a consistent finding.^{30 33} Finally, multiple AVMs and low-flow telangiectasias are thought to occur with greater frequency in this population (Figures 2 and 3).^{19 20 23 24 26 28 40 41 42 43}

View larger version (84K): [in this window] [in a new window]   Figure 2. Case 8. Cerebral angiogram demonstrating 3 small AVMs in a patient with HHT. Lateral (A) and anteroposterior (B) views of the posterior circulation demonstrate small AVMs in the medial left temporal lobe and the left cerebellum. There were additional AVMs noted in the right frontal lobe and left parietal lobe (not shown). A nidus of abnormal vessels is seen in each case.

View larger version (86K): [in this window] [in a new window]   Figure 3. Case 5. Lateral views of the left carotid (A) and vertebral (B) angiograms 4 years after radiosurgery for a right occipital AVM. The AVM is no longer seen. Multiple small telangiectasias that lack a nidus are demonstrated in both anterior and posterior circulations. We advised against treatment for these telangiectasias.

In the present series, the risk of presenting with an intracerebral hemorrhage from a cerebral AVM in patients with HHT was very low, occurring in 7 (2.1%) of 321 patients. This is supported by Fulbright et al,²⁶ who found no history of intracranial hemorrhage in a series of 184 patients with HHT. Willemse et al²⁷ encountered 3 cases of intracranial hemorrhage in their series of 196 patients (1.5%). Taken together, these data suggest that the overall long-term risk of intracranial hemorrhage among all people with HHT is likely low. Furthermore, our data suggest that many patients who do present with intracranial hemorrhage may have a good functional outcome.

We believe that all patients with a history of symptomatic intracranial hemorrhage in this study population were identified. Nevertheless, as with any retrospective analysis, the results of this study should be interpreted with caution. It is not possible, based on these data, to determine lifetime risk or annual risk of hemorrhage. We were unable to determine whether there was referral bias at our institution for HHT patients with cerebrovascular manifestations versus those patients with HHT in the absence of these symptoms. The rarity of intracranial hemorrhage in the HHT population seen at other centers would argue against such bias.²⁷

The average age of hemorrhage in this series was in the third decade. Young age at the time of hemorrhage has been observed in multiple case reports and case series.^{14 20 22 41 42 43 44} There are 5 prior reports of familial AVMs in HHT.^{20 45 46 47 48} Our series includes 3 patients harboring an AVM who were sibling members of a single family. It is possible that a family history of a first-degree relative with a cerebral AVM or intracranial hemorrhage may be a risk factor for AVM in the HHT population, but more data are needed to clarify this relationship.

Pulmonary AVFs are frequently encountered in patients with HHT and are known to predispose patients to paradoxical emboli and neurological complications. Pulmonary AVFs are the most frequent cause of neurological symptoms in this population.¹⁴ Approximately 20% of patients with HHT will develop a pulmonary AVF,^{12 13 49} and between one fourth and one third of HHT patients with pulmonary AVFs will develop cerebral ischemic symptoms.^{12 14 50 51 52} Brain abscesses from septic emboli occur in 5% to 9% of HHT patients with pulmonary AVFs.^{12 40 50 52 53 54} Others have noted a high occurrence of cases of migraine headaches in patients with HHT and pulmonary AVFs.⁵⁵ It remains unsettled whether this frequent finding represents an increase over the normal incidence of migraine headaches in the population.⁵⁶

Our data confirm the high risk of cerebral ischemic complications and abscesses in patients with HHT that is related to pulmonary AVFs. A history of cerebral embolic complications referable to a pulmonary AVF was rare in young patients but became much more common in the fourth through sixth decades. Given the frequent occurrence of neurological complications of pulmonary AVFs, strong consideration should be given both to screening patients with HHT for asymptomatic fistulae and to treating these fistulae once they are discovered. The most frequent means of screening for pulmonary AVF at our institution is arterial blood gas analysis, chest radiography, and physical examination. When clinically indicated, based on clinical suspicion alone or a positive result on one of the screening tests, a pulmonary angiogram, the most sensitive test for pulmonary AVF, is obtained.

Conclusions
Regarding cerebral vascular malformations, the risk of having a symptomatic intracranial vascular malformation or intracranial hemorrhage in this population appears to be low. With the information that is currently available, we do not see a compelling indication for routine screening of all patients with HHT for asymptomatic cerebral vascular malformations. If cerebral AVMs are discovered that have not hemorrhaged, treatment of the AVM should be performed in accordance with standard neurosurgical principles for the management of AVMs in the general population. There are no data to support the neurosurgical treatment of asymptomatic cerebral telangiectasias in patients with HHT.

	Acknowledgments

 
The authors wish to express their appreciation to Mary Soper for assistance with the preparation of this manuscript.

Received August 15, 2000; revision received November 22, 2000; accepted January 3, 2001.

	References

Top Abstract Introduction Subjects and Methods Results Discussion References

 
1. Porteous MEM, Burn J, Proctor SJ. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet. 1992;29:527–530.[Abstract/Free Full Text]

2. Garland HG, Annig ST. Hereditary haemorrhagic telangiectasia: genetic and biographical study. Br J Dermatol. 1950;62:289–310.

3. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Hembold EA, Markel DS, McKinnon WC, Murrel J. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nat Genet. 1994;8:345–351.[Medline] [Order article via Infotrieve]

4. Shovlin CL, Hughs JM, Tuddenham EG, Temperley I, Porembelon YF, Scott J, Seidman CE, Seidman JG. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet. 1994;6:205–209.[Medline] [Order article via Infotrieve]

5. Heutink P, Haitjema T, Breedveld GJ. Linkage of hereditary haemorrhagic telangiectasia to chromosome k9q34 and evidence for locus heterogeneity. J Med Genet. 1994;31:933–936.[Abstract/Free Full Text]

6. Vincent P, Plauchu H, Hazan J, Faure S, Weissenbach J, Godet J. A third locus for hereditary hemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet. 1995;4:945–949.[Abstract/Free Full Text]

7. McDonald MT, Papenberg KA, Ghosh S, Glatfelter AA, Biesecke BB, Humbold EA, Markel DS, Zolotor A, McKinnon WC, Vanderstoop JL. A disease locus for hereditary hemorrhagic telangiectasia maps to chromosome 9q33–34. Nat Genet. 1994;6:197–202.[Medline] [Order article via Infotrieve]

8. Peery WH. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med. 1987;82:989–998.[Medline] [Order article via Infotrieve]

9. Haitjema T, Westermann CJJ, Overtoom TTC, Timmer R, Disch F, Mauser H, Lammers JJ. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Arch Intern Med. 1996;156:714–719.[Abstract/Free Full Text]

10. AAssar OS, Friedman CM, White RI. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope. 1991;101:977–980.[Medline] [Order article via Infotrieve]

11. Vase P, Grove O. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia. Gastroenterology. 1986;91:1079–1083.[Medline] [Order article via Infotrieve]

12. Swanson KL, Prakash UBS, Stanson A. Pulmonary arteriovenous fistulas: Mayo Clinic experience 1982–1997. Mayo Clin Proc. 1999;74:671–680.[Abstract]

13. Dines DE, Arms RA, Bernatz PA, Gomes MR. Pulmonary arteriovenous fistulas. Mayo Clin Proc. 1974;49:460–465.[Medline] [Order article via Infotrieve]

14. Roman G, Fisher M, Perl DP, Poser CM. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and a review of the literature. Ann Neurol. 1978;4:130–144.[Medline] [Order article via Infotrieve]

15. Brown RD, Jr, Wiebers DO, Torner J, O’Fallon WM. The incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965–1992. Neurology. 1996;46:949–952.[Abstract/Free Full Text]

16. Brown RD, Jr, Wiebers DO, Torner J, O’Fallon WM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted County, Minnesota. J Neurosurg. 1996;85:29–32.[Medline] [Order article via Infotrieve]

17. Grollmus J, Hoff J. Multiple aneurysms associated with Osler-Weber-Rendu disease. Surg Neurol. 1973;1:91–93.[Medline] [Order article via Infotrieve]

18. Coubes P, Humbertclaude V, Rodesch G, Lasjaunias P, Echenne B, Frerebeau P. Total endovascular occlusion of a giant direct arteriovenous fistula in the posterior fossa in a case of Rendu-Osler-Weber disease. Child’s Nerv Syst. 1996;12:785–788.[Medline] [Order article via Infotrieve]

19. Aesch B, Lioret E, de Toffol B, Jan M. Multiple cerebral angiomas and Rendu-Osler-Weber disease: case report. Neurosurgery. 1991;29:599–602.[Medline] [Order article via Infotrieve]

20. Kadoya C, Momota Y, Ikegami Y, Urasaki E, Wada S, Yokota A. Central nervous system arteriovenous malformations with hereditary hemorrhagic telangiectasia: report of a family with three cases. Surg Neurol. 1994;42:234–239.[Medline] [Order article via Infotrieve]

21. Sobel D, Norman D. CNS manifestations of hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol. 1984;5:569–573.[Abstract]

22. Kikuchi K, Kowada M, Sasajima H. Vascular malformations of the brain in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). Surg Neurol. 1994;41:374–380.[Medline] [Order article via Infotrieve]

23. Kawaguchi T, Fujita S, Yamada H, Nishida Y, Izawa I. Multiple cerebral and pulmonary arteriovenous malformations in association with brain and subcutaneous abscesses: a possible variant of hereditary hemorrhagic telangiectasia: case report. Neurol Med Chir (Tokyo). 1990;30:272–276.[Medline] [Order article via Infotrieve]

24. Reddy K, West M, McClarty B. Multiple intracerebral arteriovenous malformations: a case report and literature review. Surg Neurol. 1987;27:495–499.[Medline] [Order article via Infotrieve]

25. Djindjian R. Spinal vascular malformations. J Neurosurg. 1976;45:727–728.[Medline] [Order article via Infotrieve]

26. Fulbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK, Fayad PB, Awad IA, White RI. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol. 1998;19:477–484.[Abstract]

27. Willemse RB, Mager JJ, Westermann CJJ, Overtoom TTC, Mauser H, Wolbers JG. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2000;92:779–784.[Medline] [Order article via Infotrieve]

28. Putman CM, Chaloupka JC, Fulbright RK, Awad IA, White RI, Fayad PB. Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). AJNR Am J Neuroradiol. 1996;17:1733–1742.[Abstract]

29. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scott Med J. 1957;2:200–215.[Medline] [Order article via Infotrieve]

30. Brown RD, Weibers DO, Forbes G, O’Fallon WM, Piepgras DG, Marsh WR, Maciunas RJ. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg. 1988;68:353–357.

31. Jane JA, Kassell NF, Torner JC, Winn HR. The natural history of aneurysms and arteriovenous malformations. J Neurosurg. 1985;62:321–323.[Medline] [Order article via Infotrieve]

32. Crawford PM, West CR, Chadwick DW, Shaw MD. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry. 1986;49:1–10.[Abstract/Free Full Text]

33. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990;73:387–391.[Medline] [Order article via Infotrieve]

34. Teragaki M, Akioka K, Yasuda M, Ikuno Y, Oku H, Takeuchi K, Takeda T. Hereditary hemorrhagic telangiectasias with growing arteriovenous fistulas followed for 24 years. Am J Med Sci. 1988;295:545–547.

35. Swinburne AJ, Eedullo AJ, Gangemi R, Mijangos JA. Hereditary telangiectasia and multiple arteriovenous fistulas: clinical deterioration during pregnancy. Chest. 1986;89:459–460.[Abstract/Free Full Text]

36. Laroch CM, Wells E, Shneerson J. Massive hemothorax due to enlarging arteriovenous fistula in pregnancy. Chest. 1992;101:1452–1454.[Abstract/Free Full Text]

37. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32:291–297.

38. Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg. 1983;58:331–337.[Medline] [Order article via Infotrieve]

39. Spetzler RF, Hargraves RW, McCormick PW, Zabramski JM, Flom RA, Zimmerman RS. Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg. 1992;76:918–923.[Medline] [Order article via Infotrieve]

40. Adams HP, Subbiah B, Bosch EP. Neurological aspects of hereditary hemorrhagic telangiectasia: report of two cases. Arch Neurol. 1977;34:101–104.[Abstract/Free Full Text]

41. Hanieh A, Blumbergs PC, Carney PG. Multiple cerebral arteriovenous malformations associated with soft tissue vascular malformations. J Neurosurg. 1981;54:670–672.[Medline] [Order article via Infotrieve]

42. Waller JD, Greenberg JH, Lewis CW. Hereditary hemorrhagic telangiectasia with cerebrovascular malformations. Arch Dermatol. 1976;112:49–52.[Abstract/Free Full Text]

43. Willinsky RA, Lasjaunias P, Terbrugge K, Burrows P. Multiple cerebral arteriovenous malformations (AVMs): review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology. 1990;32:207–210.[Medline] [Order article via Infotrieve]

44. John PR. Early childhood presentation of neurovascular disease in hereditary hemorrhagic telangiectasia. Pediatr Radiol. 1992;22:140–141.[Medline] [Order article via Infotrieve]

45. TerBerg JWM, Dippel DWJ, Habbema JDF, Westermann CJJ, Tulleken CAF, Willemse J. Unruptured intracranial arteriovenous malformations with hereditary hemorrhagic telangiectasia: neurosurgical treatment or not? Acta Neurochir (Wien). 1993;121:34–42.[Medline] [Order article via Infotrieve]

46. Boynton RC, Morgan BC. Cerebral arteriovenous fistula with possible hereditary hemorrhagic telangiectasia. Am J Dis Child. 1973;125:99–101.[Abstract/Free Full Text]

47. King CR, Lovrien EW, Reiss J. Central nervous system arteriovenous malformations in multiple generations of a family with hereditary hemorrhagic telangiectasia. Clin Genet. 1977;12:372–381.[Medline] [Order article via Infotrieve]

48. Lesser BA, Wendt D, Miks VM, Norum RA. Identical twins with hereditary hemorrhagic telangiectasia concordant for cerebrovascular arteriovenous malformations. Am J Med. 1986;81:931–934.[Medline] [Order article via Infotrieve]

49. Hodgson CH, Kaye RL. Pulmonary arteriovenous fistula and hereditary hemorrhagic telangiectasia: a review and report of 35 cases of fistula. Dis Chest. 1963;43:449–455.[Medline] [Order article via Infotrieve]

50. White RI, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, Shuman K, Kim W, Kinnison M, Mitchell SE. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology. 1988;169:663–669.[Abstract/Free Full Text]

51. Lee DW, White RI, Egglin TK, Pollak JS, Fayad PB, Wirth JA, Rosenblatt MM, Dickey KW, Burdge CM. Embolotherapy of large pulmonary arteriovenous malformations: long-term results. Ann Thorac Surg. 1997;64:930–939.[Abstract/Free Full Text]

52. Hewes RC, Auster M, White RI. Cerebral embolism: first manifestation of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol. 1985;8:151–155.[Medline] [Order article via Infotrieve]

53. Press OW, Ramsey PG. Central nervous system infections associated with hereditary hemorrhagic telangiectasia. Am J Med. 1984;77:86–92.[Medline] [Order article via Infotrieve]

54. Dyer NH. Cerebral abscess in hereditary hemorrhagic telangiectasia: report of two cases in a family. J Neurol Neurosurg Psychiatry. 1967;30:563–567.[Free Full Text]

55. Steele JG, Nath PU, Burn J, Porteus ME. An association between migrainous aura and hereditary hemorrhagic telangiectasia. Headache. 1993;33:145–148.[Medline] [Order article via Infotrieve]

56. Rozen TD, Swanson JW, Stang PE, McDonnel SK, Rocca WA. Increasing incidence of medically recognized migraine headache in a United States population. Neurology. 1999;53:1468–1473.[Abstract/Free Full Text]

This article has been cited by other articles:

				P. A. Murphy, M. T. Y. Lam, X. Wu, T. N. Kim, S. M. Vartanian, A. W. Bollen, T. R. Carlson, and R. A. Wang Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice PNAS, August 5, 2008; 105(31): 10901 - 10906. [Abstract] [Full Text] [PDF]

				M. C. Post and W. Budts The Relationship Between Migraine and Right-to-Left Shunt: Fact or Fiction? Chest, September 1, 2006; 130(3): 896 - 901. [Abstract] [Full Text] [PDF]

				N L Prigoda, S Savas, S A Abdalla, B Piovesan, D Rushlow, K Vandezande, E Zhang, H Ozcelik, B L Gallie, and M Letarte Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations J. Med. Genet., September 1, 2006; 43(9): 722 - 728. [Abstract] [Full Text] [PDF]

				R Cohen, L Cabanes, C Burckel, D Duboc, and E Touze Pulmonary arteriovenous fistulae thrombosis responsible for recurrent stroke J. Neurol. Neurosurg. Psychiatry, May 1, 2006; 77(5): 707 - 708. [Full Text] [PDF]

				M. Gallitelli, G. Pasculli, T. Fiore, A. Carella, and C. Sabba Emergencies in hereditary haemorrhagic telangiectasia QJM, January 1, 2006; 99(1): 15 - 22. [Abstract] [Full Text] [PDF]

				M. C. Post, T. G. W. Letteboer, J. J. Mager, T. H. Plokker, J. C. Kelder, and C. J. J. Westermann A Pulmonary Right-to-Left Shunt in Patients With Hereditary Hemorrhagic Telangiectasia Is Associated With an Increased Prevalence of Migraine Chest, October 1, 2005; 128(4): 2485 - 2489. [Abstract] [Full Text] [PDF]

				J. F. Meschia, T. G. Brott, and R. D. Brown Jr Genetics of Cerebrovascular Disorders Mayo Clin. Proc., January 1, 2005; 80(1): 122 - 132. [Abstract] [PDF]

				J. Jaskolka, L. Wu, R. P. Chan, and M. E. Faughnan Imaging of Hereditary Hemorrhagic Telangiectasia Am. J. Roentgenol., August 1, 2004; 183(2): 307 - 314. [Full Text] [PDF]

				M. Maarouf, M. Runge, M. Kocher, M. Zahringer, H. Treuer, and V. Sturm Radiosurgery for cerebral arteriovenous malformations in hereditary hemorrhagic telangiectasia Neurology, July 27, 2004; 63(2): 367 - 369. [Abstract] [Full Text] [PDF]

				V. Cottin, H. Plauchu, J.-Y. Bayle, M. Barthelet, D. Revel, and J.-F. Cordier Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 994 - 1000. [Abstract] [Full Text] [PDF]

				J Berg, M Porteous, D Reinhardt, C Gallione, S Holloway, T Umasunthar, A Lux, W McKinnon, D Marchuk, and A Guttmacher Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations J. Med. Genet., August 1, 2003; 40(8): 585 - 590. [Abstract] [Full Text] [PDF]

				A J Easey, G M F Wallace, J M B Hughes, J E Jackson, W J Taylor, and C L Shovlin Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22 061 years of HHT patient life J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 743 - 748. [Abstract] [Full Text] [PDF]

				H. J. Cloft Spontaneous Regression of Cerebral Arteriovenous Malformation in Hereditary Hemorrhagic Telangiectasia AJNR Am. J. Neuroradiol., June 1, 2002; 23(6): 1049 - 1050. [Abstract] [Full Text] [PDF]

				J. Mandzia, K. Henderson, M. Faughnan, R. White Jr, C. O. Maher, D. G. Piepgras, R. D. Brown Jr, J. A. Friedman, and B. E. Pollock Compelling Reasons to Screen Brain in HHT Response Stroke, December 1, 2001; 32(12): 2957 - 2958. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maher, C. O. Articles by Pollock, B. E. Search for Related Content PubMed PubMed Citation Articles by Maher, C. O. Articles by Pollock, B. E. Related Collections Acute Cerebral Hemorrhage Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Genetics of Stroke Angiography Intracerebral Hemorrhage Risk Factors for Stroke Aneurysm, AVM, hematoma